Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2025-06-18 00:00:00 ET · period of report 2025-06-16 · accession 0001823239-25-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-18 | 2025-06-16 | MRVI | ECKERT R ANDREW | Dir | A - Grant | $2.16 | +231.5K | 365.9K | +172% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-16 | A | A | 231,481 | $2.16 | 365,890 | D | — | — | (F1) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon Vesting. One-half (1/2) of the RSUs shall be fully vested upon the date of grant, and the remaining RSUs shall vest on May 22, 2026, the one-year anniversary of the date of the 2025 Annual Meeting of Shareholders of the Company. |